Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
4
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
cancer
cancer immunotherapy
cystic fibrosis
drug prices
investing
pfizer
takeda pharmaceutical
aduro biotech
What
bio
4
×
roundup
crispr
drug
acquisitions
ahead
albert
alliance
alzheimer’s
asco
biggest
bourla
branded
bristol
buy
calls
ceo
changing
choices
color
commissioner
companies
company
consumers
costly
counterweight
days
different
drugs
elevatebio
fail
fda
future
gene
generic
graft
growing
hours
imports
increases
Language
unknown
unset
Current search:
roche
×
bio
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More